Orthofix International N.V. (NASDAQ:OFIX) – Equities researchers at SunTrust Banks boosted their Q3 2017 earnings estimates for shares of Orthofix International N.V. in a research report issued on Tuesday. SunTrust Banks analyst B. Nudell now expects that the medical device company will earn $0.36 per share for the quarter, up from their prior estimate of $0.35. SunTrust Banks has a “Buy” rating and a $49.00 price target on the stock. SunTrust Banks also issued estimates for Orthofix International N.V.’s Q4 2017 earnings at $0.51 EPS, Q3 2018 earnings at $0.46 EPS and FY2018 earnings at $1.95 EPS.

Several other research firms have also commented on OFIX. BidaskClub lowered Orthofix International N.V. from a “buy” rating to a “hold” rating in a research report on Tuesday, August 1st. Zacks Investment Research upgraded Orthofix International N.V. from a “sell” rating to a “hold” rating in a research report on Thursday, July 6th. Ladenburg Thalmann Financial Services started coverage on Orthofix International N.V. in a research report on Wednesday, June 14th. They set a “buy” rating and a $53.25 price target for the company. BTIG Research started coverage on Orthofix International N.V. in a research report on Wednesday, June 21st. They set a “buy” rating and a $52.00 price target for the company. Finally, Langenberg & Company restated a “buy” rating and set a $53.25 price target on shares of Orthofix International N.V. in a research report on Wednesday, June 14th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $52.30.

TRADEMARK VIOLATION WARNING: This piece was first published by Watch List News and is the property of of Watch List News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://www.watchlistnews.com/q3-2017-eps-estimates-for-orthofix-international-n-v-ofix-boosted-by-analyst/1468261.html.

Shares of Orthofix International N.V. (OFIX) opened at 47.35 on Thursday. The firm has a 50 day moving average price of $45.59 and a 200 day moving average price of $40.76. Orthofix International N.V. has a one year low of $32.51 and a one year high of $49.60. The stock’s market capitalization is $854.38 million.

Orthofix International N.V. (NASDAQ:OFIX) last issued its earnings results on Monday, August 7th. The medical device company reported $0.42 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a return on equity of 9.96% and a net margin of 1.88%. The business had revenue of $108.90 million during the quarter, compared to analysts’ expectations of $102.94 million. During the same period in the prior year, the business earned $0.41 EPS. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Gabelli Funds LLC raised its position in Orthofix International N.V. by 0.3% in the first quarter. Gabelli Funds LLC now owns 291,450 shares of the medical device company’s stock worth $11,119,000 after buying an additional 1,000 shares during the period. UBS Asset Management Americas Inc. bought a new position in Orthofix International N.V. during the first quarter worth about $229,000. Comerica Bank bought a new position in Orthofix International N.V. during the first quarter worth about $783,000. BNP Paribas Arbitrage SA raised its position in Orthofix International N.V. by 68.9% in the first quarter. BNP Paribas Arbitrage SA now owns 4,656 shares of the medical device company’s stock worth $178,000 after buying an additional 1,900 shares during the period. Finally, Bank of New York Mellon Corp raised its position in Orthofix International N.V. by 122.5% in the first quarter. Bank of New York Mellon Corp now owns 242,068 shares of the medical device company’s stock worth $9,236,000 after buying an additional 133,281 shares during the period. Hedge funds and other institutional investors own 99.68% of the company’s stock.

Orthofix International N.V. Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Earnings History and Estimates for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.